NasdaqGS - Nasdaq Real Time Price USD
Ionis Pharmaceuticals, Inc. (IONS)
35.29
+0.05
+(0.14%)
At close: June 6 at 4:00:01 PM EDT
35.72
+0.43
+(1.22%)
After hours: June 6 at 5:11:27 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 323,666 | 23 |
| Sales | 167,029 | 24 |
| Net Shares Purchased (Sold) | 156,637 | 47 |
| Total Insider Shares Held | 1.33M | -- |
| % Net Shares Purchased (Sold) | 13.30% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| HAYDEN MICHAEL REUBEN Director | Purchase at price 31.86 per share. | Direct | 477,900 | May 1, 2025 |
| JENNE KYLE Officer | Sale at price 28.36 per share. | Direct | 85,534 | Apr 16, 2025 |
| BAROLDI JOSEPH Officer | Sale at price 28.40 per share. | Direct | 111,555 | Apr 16, 2025 |
| BIRCHLER BRIAN Officer | Sale at price 28.37 per share. | Direct | 19,292 | Apr 16, 2025 |
| JENNE KYLE Officer | -- | Direct | -- | Apr 15, 2025 |
| BAROLDI JOSEPH Officer | -- | Direct | -- | Apr 15, 2025 |
| BIRCHLER BRIAN Officer | -- | Direct | -- | Apr 15, 2025 |
| MONIA BRETT P Chief Executive Officer | Sale at price 32.32 per share. | Direct | 4,525 | Mar 11, 2025 |
| O'NEIL PATRICK R General Counsel | Sale at price 32.35 per share. | Direct | 39,046 | Feb 20, 2025 |
| O'NEIL PATRICK R General Counsel | Sale at price 31.62 per share. | Direct | 194,939 | Feb 4, 2025 |
| MONIA BRETT P Chief Executive Officer | Sale at price 31.65 per share. | Direct | 1,229,463 | Feb 4, 2025 |
| O'NEIL PATRICK R General Counsel | Sale at price 32.49 per share. | Direct | 45,685 | Jan 31, 2025 |
| SWAYZE ERIC E Officer | Sale at price 32.31 per share. | Direct | 44,162 | Jan 31, 2025 |
| MONIA BRETT P Chief Executive Officer | Sale at price 32.45 per share. | Direct | 429,655 | Jan 31, 2025 |
| SCHNEIDER EUGENE Officer | Sale at price 32.20 per share. | Direct | 47,780 | Jan 31, 2025 |
| GEARY RICHARD S Officer | Sale at price 32.40 per share. | Direct | 45,561 | Jan 31, 2025 |
| BENNETT C FRANK Officer | Sale at price 32.46 per share. | Direct | 43,079 | Jan 31, 2025 |
| HOUGEN ELIZABETH L Chief Financial Officer | Sale at price 32.44 per share. | Direct | 49,404 | Jan 31, 2025 |
| BENNETT C FRANK Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 30, 2025 |
| HOUGEN ELIZABETH L Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 30, 2025 |
| GEARY RICHARD S Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 30, 2025 |
| MONIA BRETT P Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 30, 2025 |
| O'NEIL PATRICK R General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 30, 2025 |
| SWAYZE ERIC E Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 30, 2025 |
| SCHNEIDER EUGENE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 30, 2025 |
| O'NEIL PATRICK R General Counsel | Sale at price 32.83 per share. | Direct | 241,629 | Jan 16, 2025 |
| SWAYZE ERIC E Officer | Sale at price 32.70 - 32.84 per share. | Indirect | 235,678 | Jan 16, 2025 |
| MONIA BRETT P Chief Executive Officer | Sale at price 32.63 per share. | Direct | 1,091,444 | Jan 16, 2025 |
| BAROLDI JOSEPH Officer | Sale at price 32.70 per share. | Indirect | 144,861 | Jan 16, 2025 |
| SCHNEIDER EUGENE Officer | Sale at price 32.79 per share. | Direct | 213,889 | Jan 16, 2025 |
| BIRCHLER BRIAN Officer | Sale at price 32.70 per share. | Direct | 176,580 | Jan 16, 2025 |
| DEVERS SHANNON L Officer | Sale at price 32.78 per share. | Direct | 139,855 | Jan 16, 2025 |
| GEARY RICHARD S Officer | Sale at price 32.86 per share. | Direct | 232,407 | Jan 16, 2025 |
| BENNETT C FRANK Officer | Sale at price 32.90 per share. | Direct | 222,114 | Jan 16, 2025 |
| HOUGEN ELIZABETH L Chief Financial Officer | Sale at price 32.81 per share. | Direct | 290,989 | Jan 16, 2025 |
| HOUGEN ELIZABETH L Chief Financial Officer | -- | Direct | -- | Jan 15, 2025 |
| BENNETT C FRANK Officer | -- | Direct | -- | Jan 15, 2025 |
| O'NEIL PATRICK R General Counsel | -- | Direct | -- | Jan 15, 2025 |
| SWAYZE ERIC E Officer | -- | Indirect | -- | Jan 15, 2025 |
| BAROLDI JOSEPH Officer | -- | Indirect | -- | Jan 15, 2025 |
| SCHNEIDER EUGENE Officer | -- | Direct | -- | Jan 15, 2025 |
| BIRCHLER BRIAN Officer | -- | Direct | -- | Jan 15, 2025 |
| DEVERS SHANNON L Officer | -- | Direct | -- | Jan 15, 2025 |
| MONIA BRETT P Chief Executive Officer | -- | Direct | -- | Jan 15, 2025 |
| YANG MICHAEL J. Director | -- | Direct | -- | Jan 15, 2025 |
| GEARY RICHARD S Officer | -- | Direct | -- | Jan 15, 2025 |
| HAYDEN MICHAEL REUBEN Director | Purchase at price 36.20 - 36.23 per share. | Direct | 181,079 | Dec 23, 2024 |
| SWAYZE ERIC E Officer | Sale at price 37.92 per share. | Direct | 45,278 | Nov 12, 2024 |
| MONIA BRETT P Chief Executive Officer | Sale at price 38.05 per share. | Direct | 252,294 | Nov 12, 2024 |
| LOSCALZO JOSEPH Director | Sale at price 37.86 per share. | Direct | 511,426 | Nov 12, 2024 |
Related Tickers
ARWR Arrowhead Pharmaceuticals, Inc.
16.81
+2.13%
ALNY Alnylam Pharmaceuticals, Inc.
300.83
-2.33%
PTCT PTC Therapeutics, Inc.
52.13
+0.77%
RVMD Revolution Medicines, Inc.
41.09
+2.21%
AGIO Agios Pharmaceuticals, Inc.
34.33
+2.23%
RARE Ultragenyx Pharmaceutical Inc.
37.17
+0.69%
BMRN BioMarin Pharmaceutical Inc.
56.65
+2.50%
ACAD ACADIA Pharmaceuticals Inc.
21.98
+3.00%
CYTK Cytokinetics, Incorporated
32.30
+0.69%
AKRO Akero Therapeutics, Inc.
54.28
+0.63%